Skip to main content
Premium Trial:

Request an Annual Quote

Velcura Therapeutics, Scripps-PARC Institute for Advanced Biomedical Sciences

Premium

Velcura Therapeutics has developed a custom Affymetrix GeneChip array for monitoring changes in gene expression during human bone formation. The array will be used for researching osteoporosis and other bone diseases. The custom chip is available solely to Velcura for use within its own research labs and to Velcura’s strategic partners.


The Scripps-PARC Institute for Advanced Biomedical Sciences, a joint venture of the Scripps Research Institute and the Palo Alto Research Center, has developed a nanocalorimeter that it believes will enable researchers to design new drugs more quickly. The enthalpy array technology uses 250 nanoliter droplets of a test compound on 96-detector arrays and allows researchers to characterize larger numbers of samples in a shorter amount of time than traditional methods, the partners said.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.